Questions

826. Deputy Paul Nicholas Gogarty asked the Minister for Health the steps she has taken to ensure that eligibility criteria for givinostat are aligned with the NICE approach, ensuring access for boys who can walk or who can stand with or without support, in order that boys here are not disadvantaged compared to those in the Northern Ireland and receive equitable access to treatment; and if she will make a statement o…

366. Deputy Paul Nicholas Gogarty asked the Minister for Health if her Department or the HSE has assessed the impact of overnight partner restrictions on postnatal anxiety, depression, breastfeeding, dignity, safety and maternal wellbeing; and if she will make a statement on the matter. [44912/26]

367. Deputy Paul Nicholas Gogarty asked the Minister for Health her views on whether blanket overnight restrictions after childbirth is acceptable; and if she will make a statement on the matter. [44913/26]

368. Deputy Paul Nicholas Gogarty asked the Minister for Health if exceptions to overnight partner restrictions will be considered for private rooms, caesarean sections, traumatic births, anxiety, breastfeeding difficulties, mobility issues or other clinical and emotional support needs; and if she will make a statement on the matter. [44914/26]

369. Deputy Paul Nicholas Gogarty asked the Minister for Health whether her Department will consider a national standard for family-centred postnatal care, including overnight partner support where the mother requests it; and if she will make a statement on the matter. [44915/26]

2042. Deputy Paul Nicholas Gogarty asked the Minister for Health if there are plans to expand the reach of a centre (details supplied) to tackle the shortage in public health nurses who are able to provide developmental checks to children in the surrounding area; and if she will make a statement on the matter. [42456/26]

2043. Deputy Paul Nicholas Gogarty asked the Minister for Health if there are plans to provide further funding to adequately ensure that a centre (details supplied) is staffed in accordance with the population in the area; and if she will make a statement on the matter. [42457/26]

2106. Deputy Paul Nicholas Gogarty asked the Minister for Health the basis on which the HPRA authorised three recent ALURES projects involving potential use of 1,172 dogs and 932 cats over 60 month periods; the scrutiny applied to the necessity, proportionality, and welfare implications of these numbers; the identity of the project holders, establishments, animal sources, and products involved; the number of animals …

259. Deputy Paul Nicholas Gogarty asked the Minister for Health if the five consultant neurologists recruited by the HSE to support the Neurology Model of Care and the 'Hub and Spoke' model, which includes services for functional neurological disorder (FND) patients, are in place, and currently working to support people who suffer from FND; and if she will make a statement on the matter. [31041/26]

260. Deputy Paul Nicholas Gogarty asked the Minister for Health following the €4 million increase in Budget 2025 to provide additional services to patients who suffer from functional neurological disorder (FND), if there are plans to gradually increase the amount allocated to this section in the future (details supplied); and if she will make a statement on the matter. [31042/26]

261. Deputy Paul Nicholas Gogarty asked the Minister for Health the current treatments available to patients who suffer from functional neurological disorder in Ireland; if there are plans to make this more accessible to patients in Ireland in the future; and if she will make a statement on the matter. [31043/26]

323. Deputy Paul Nicholas Gogarty asked the Minister for Health if she is aware of the barriers currently faced by patients in Ireland living with lipoedema, including the absence of a published national HSE care pathway, limited access to conservative management such as compression therapy and manual lymphatic drainage, and delays or difficulties accessing treatment through the Cross-Border Healthcare Directive; the…

324. Deputy Paul Nicholas Gogarty asked the Minister for Health whether the HSE working group established in 2023 to develop a national care pathway for lipoedema has completed its work; when the pathway is expected to be published; and whether patient advocacy organisations (details supplied) will be included in the development and implementation of this pathway. [22558/26]

325. Deputy Paul Nicholas Gogarty asked the Minister for Health if her Department intends to review the operation of private health insurers in relation to coverage for medically indicated liposuction procedures for lipoedema patients, in light of concerns regarding inconsistent decision-making, the use of criteria designed for lymphoedema rather than lipoedema, and practices that may result in patients being forced …

326. Deputy Paul Nicholas Gogarty asked the Minister for Health if any specific funding can be made available for the placement of a person (details supplied); and if a statement can be made on the matter. [22560/26]

946. Deputy Paul Nicholas Gogarty asked the Minister for Health the reason for the significant delays in advancing the assisted human reproduction legislation; and if she will make a statement on the matter. [17061/26]

947. Deputy Paul Nicholas Gogarty asked the Minister for Health the measures in place to protect the rights of children in ‘legal limbo’ whilst the assisted human reproduction legislation remains stalled; and if she will make a statement on the matter. [17062/26]

909. Deputy Paul Nicholas Gogarty asked the Minister for Health if she, or her officials, have sought clarification from the HSE regarding its decision to submit to limit the scope of an inquest (details supplied), and requested an explanation as to how restricting the scope of the inquest serves the public interest; if such engagement has not yet taken place, when it will occur. [14514/26]

910. Deputy Paul Nicholas Gogarty asked the Minister for Health the specific steps she proposes to take to ensure that the concerns raised by persons (details supplied) are not only heard by those with the power to effect change, but that their lived experiences are meaningfully considered and translated into concrete action. [14515/26]

911. Deputy Paul Nicholas Gogarty asked the Minister for Health in engaging with the HSE regarding its decision to challenge the scope of an inquest (details supplied), to outline whether she will also seek clarification as to the role played by the State Claims Agency in that decision; whether she considers it appropriate for the State Claims Agency to have any involvement in submissions made within the coronial pro…

912. Deputy Paul Nicholas Gogarty asked the Minister for Health if there are grounds to examine whether the HSE’s actions in relation to the scope of an inquest (details supplied), as raised during Leader's Questions on 27 January 2026, could constitute undue interference contrary to the public interest; the basis for that view. [14517/26]

1002. Deputy Paul Nicholas Gogarty asked the Minister for Health her views on measures aimed at improving mental health care and treatment, strengthening diagnosis, ensuring robust management of prescription medication, providing for the inclusion and support of co-parents in line with the Finnish model, and reducing risks to children (details supplied); the reason she proceeded with the Mental Health Bill 2025 witho…

1077. Deputy Paul Nicholas Gogarty asked the Minister for Health whether there are notable regional variations in approval rates for a primary medical certificate; and if she will make a statement on the matter. [15014/26]

1078. Deputy Paul Nicholas Gogarty asked the Minister for Health the approximate percentage in recent years of applicants for a primary medical certificate suffering with Parkinson’s Disease (details supplied), which have been granted at initial stage or on appeal; and if she will make a statement on the matter. [15015/26]

1010. Deputy Paul Nicholas Gogarty asked the Minister for Health the circumstances in which a person’s next-of-kin would need to be consulted in relation to palliative sedation/midazolam in cases in which the person is at the hospital, clinic or nursing home; and if she will make a statement on the matter. [4228/26]